{
    "title": "Merck, Moderna detail potential skin cancer vaccine progress",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11533291/Merck-Moderna-potential-skin-cancer-vaccine-progress.html",
    "date": "2022-12-13",
    "keywords": [
        "cancer",
        "vaccine",
        "merck",
        "moderna",
        "study",
        "skin",
        "phase",
        "tuesday",
        "technology",
        "midstage",
        "tumor",
        "file",
        "covid19",
        "melanoma",
        "combination",
        "spikevax",
        "cambridge",
        "system",
        "year",
        "stock",
        "maker",
        "progress",
        "preventive",
        "shot",
        "form",
        "company",
        "keytruda",
        "improvement",
        "survival",
        "stephane",
        "bancel",
        "cnbc",
        "morning",
        "stage",
        "research",
        "drug",
        "approval",
        "drugmaker",
        "quarter",
        "sign",
        "entrance",
        "building",
        "mass",
        "monday",
        "ap",
        "photobill",
        "use",
        "revenue",
        "dna",
        "trial",
        "vaccinekeytruda",
        "seller",
        "bodys",
        "immune",
        "patient",
        "group",
        "reduction",
        "risk",
        "death",
        "disease",
        "approach",
        "agreement",
        "share",
        "collaboration",
        "inc",
        "midday",
        "trading",
        "co",
        "tom",
        "murphy",
        "twitter",
        "httpstwittercomthpmurphy",
        "photo",
        "headquarters",
        "kenilworth",
        "wenig"
    ],
    "category": [
        "wires",
        "ap"
    ]
}